Therapeutic Areas: Dermatology | Oncology | Family Medicine

Melanoma Clinical Trials


A listing of Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Birmingham : Alabama Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Birmingham : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Birmingham : University of Alabama Comprehensive Cancer Center SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mobile : Southern Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Mobile : University of South Alabama / Mitchell Cancer Institute SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Arizona

Chandler : Ironwood Cancer & Research Centers

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gilbert : Banner MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Goodyear : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Phoenix : Phoenix Children'S Hospital Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Phoenix : Arizona Oncology Associates SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Phoenix : Phoenix Children's Hospital

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Scottsdale : Scottsdale Healthcare

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Scottsdale : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Tucson : University Arizona Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Tucson : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Tucson : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Tucson : The University of Arizona Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Tucson : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Arkansas

Fayetteville : Highlands Oncology Group SC Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Fayetteville : Highlands Oncology Group SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fayetteville : Highlands Oncology Group SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hot Springs : Genesis Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Rogers :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

California

Beverly Hills : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Beverly Hills : Beverly Hills Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Beverly HIlls : Beverly Hills Cancer Center SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Duarte : Teva Investigational Site 10672

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Encinitas : California Cancer Associates for Research Excellence (cCARE)

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

La Jolla : UC San Diego

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

La Jolla : Scripps Clinic

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Loma Linda : Loma Linda University

A clinical research study of PEG-BCT-100 for the treatment of Hepatocellular Carcinoma, Renal Cell Carcinoma, Melanoma or Prostate Adenocarcinoma

Long Beach : Pacific Shores Medical Group

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Los Angeles :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Los Angeles : Childrens Hospital Of La Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Los Angeles : Jonsson Comprehensive Cancer Center

A clinical research study of sargramostim, sentinel lymph node biopsy, laboratory biomarker analysis and hypertonic saline for the treatment of Stage IB Melanoma, Stage IIA Melanoma, Stage IIB Melanoma or Stage IIC Melanoma

Los Angeles : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Los Angeles : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Los Angeles : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Los Angeles : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Los Angeles : UCLA Hematology-Oncology Clinic

A clinical trial to evaluate treatments using MGA271 for patients

Los Angeles : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Los Angeles : Call for Information (Investigational Site 0001) Updated

A Phase 1/Phase 2 clinical study for patients with Melanoma

Los Angeles : Call for Information (Investigational Site 0003) Updated

A Phase 1/Phase 2 clinical study for patients with Melanoma

Los Angeles : Cedars Sinai Medical Center Cedars Sinai 4

A Phase 4 clinical study for patients using Pasireotide

Los Angeles : University of California Los Angeles

Combination of Temozolomide and Sunitinib in Treatment of Patients With Metastatic and Unresectable Malignant Melanoma

Los Angeles :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : UCLA Hematology-Oncology Clinic

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Los Angeles : Call for Information (Investigational Site 0001)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Los Angeles : The Angeles Clinic and Research Institute

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Los Angeles : UCLA

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Los Angeles :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Los Angeles : The Angeles Clinic and Research Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Orange : Children'S Hospital Of Orange County Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Orange : Chao Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma or Malignant Melanoma

Orange : Chao Family Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating Pazopanib and Paclitaxel for the treatment of Stage III Melanoma, Stage IV Melanoma or Unresectable Melanoma

Orange : University of California Irvine Irvine Medical Center

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pismo Beach : PCR Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

San Francisco : University of San Francisco, California

A clinical research study of Dabrafenib and Gamma Knife Radiosurgery for the treatment of BRAFV600E Melanoma Patients

San Francisco : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

San Francisco : University of California, San Francisco

A clinical trial to evaluate treatments using BKM120 Combined with Vemurafenib (PLX4032) for patients with BRAF Mutant Metastatic Melanoma

San Francisco : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

San Francisco : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

San Francisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Francisco : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Francisco : UCSF Helen Diller Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

San Luis Obispo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Santa Clara : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Santa Monica : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Santa Monica : Sarcoma Oncology Center Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Santa Monica :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Santa Monica : John Wayne Cancer Institute

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Santa Rosa : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Stanford : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Stanford : Stanford University Medical Center SC - 3

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Stanford : Stanford University Medical Center Stanford Hospital & Clinics

A Phase 4 clinical study for patients using Pasireotide

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Vallejo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Colorado

Aurora : Children'S Hospital Colorado Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Aurora : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Aurora : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Aurora : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Aurora : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Aurora :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Denver : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Englewood : AboutSkin Dermatology and DermSurgery

A clinical study for patients with Melanoma

Grand Junction : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Greenwood Village : Rocky Mountain Cancer Centers Rocky Mountain Cancer Centers Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Greenwood Village : Rocky Mountain Cancer Centers Dept of Rocky Mountain (2)

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Connecticut

New Haven : Smilow Cancer Hospital at Yale New Haven

A clinical trial to evaluate treatments using Vemurafenib for patients with Melanoma [C04.557.465.625.650.510]

New Haven : Yale Cancer Center

A Phase 1 clinical study for patients with Malignant Melanoma

New Haven : Yale School of Medicine

Patients are needed to participate in a clinical research study evaluating NY-ESO-1 for the treatment of Melanoma

New Haven : Yale University

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Norwalk : Whittingham Cancer Center Norwalk Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

District of Columbia

Washington : Georgetown Lombardi Comprehsnive Cancer Center

A Phase 2 clinical study for patients with Melanoma

Washington : Washington Cancer Institute at MedStar Washington Hospital Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Georgetown Lombardi Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Call for Information (Investigational Site 0003)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Washington : Washington Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Florida

Boynton Beach : University Cancer Institute SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fort Myers : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Fort Myers : Florida Cancer Specialists Florida Cancer Specialists (31 Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Fort Myers : Teva Investigational Site 10673

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Fort Myers : Florida Cancer Specialists SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fort Myers : Florida Cancer Specialists Dept of Onc

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Fort Myers : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hollywood : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Jacksonville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Jacksonville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Jacksonville : Cancer Specialists of North Florida Cancer Specialists (2) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Jacksonville : Cancer Specialists of North Florida

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lake Worth : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lakeland : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Lakeland : Lakeland Regional Cancer Center

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Miami :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Miami : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Miami : University of Miami SC-3

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Miami Beach : MSMC Research Program

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Miami Beach : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Miami Beach : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Miami Beach : Mount Sinai Medical Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Orlando : Clinical Site Updated

A clinical trial to evaluate treatments using HF10 plus Ipilimumab for patients with Malignant Melanoma

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Orlando : Orlando Health

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Sarasota :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

St. Petersburg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Petersburg :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Tallahassee : Dermatology Associates of Tallahassee

A clinical study for patients with Melanoma

Tampa :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Tampa : H. Lee Moffitt Cancer Center

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Tampa : H. Lee Moffitt Cancer Center and Research Institute Updated

A clinical trial to evaluate treatments using PV-10 and Surgery for patients with Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A Phase 1 clinical study for patients with Melanoma (Skin)

Tampa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute Updated

Patients are needed to participate in a clinical research study evaluating Panobinostat and Ipilimumab for the treatment of Melanoma or Skin Cancer

Tampa : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study for the treatment of Metastatic Melanoma

Tampa : Moffitt Cancer Center

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Tampa : H. Lee Moffitt Cancer Center (NSCLC)

Patients are needed to participate in a clinical research study of RTA 408 Capsules to evaluate Non-small Cell Lung Cancer

Tampa : H. Lee Moffitt Cancer Center (Melanoma)

Patients are needed to participate in a clinical research study of RTA 408 Capsules to evaluate Non-small Cell Lung Cancer

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of XL888 and Vemurafenib to evaluate Melanoma

Titusville : Space Coast Medical Associates Space Coast Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Georgia

Savannah : Memorial University Medical Center

CTSU/ECOG E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High-Risk Melanoma

Athens : University Cancer & Blood Center, LLC Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Atlanta : Emory University School of Medicine

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Atlanta : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Atlanta : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Atlanta : Taofeek Owonikoko, MD, PhD

Patients are needed to participate in a clinical research study of BKM120 and Everolimus to evaluate Solid Tumors

Atlanta : Emory University/Winship Cancer Institute

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Augusta : Georgia Regents University

A Phase 1/Phase 2 clinical study for patients with Metastatic Melanoma, Stage III Melanoma or Stage IV Melanoma

Augusta : Georgia Regents University

Patients are needed to participate in a clinical research study of NLG919 to evaluate Solid Tumors, Breast Cancer, Lung Cancer or Pancreatic Cancer

Marietta : NorthWest Georgia Oncology Centers SC Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Newnan : Southeastern Regional Medical Center Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Illinois

Elgin : Advocate Sherman Hospital

ECOG E1609 Phase III Randomized Study of Adjuvant Ipilimumab Versus High-Dose Recombinant Interferon Alfa-2b in Patients With High-Risk Stage IIIB, IIIC, or IV Melanoma

Chicago :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Chicago : Lurie Children's Hospital of Chicago Developmental Therapeutics Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Chicago : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Chicago : The University of Chicago

A clinical trial to evaluate treatments using MGA271 for patients

Chicago : Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Patients are needed to participate in a clinical research study of ALS-357 to evaluate Melanoma

Chicago : University of Illinois at Chicago SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Chicago : The University of Chicago

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Maywood : Loyola University Medical Center, Div of Hematology/Oncology

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Niles : Oncology Specialists, S.C

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Park Ridge : Luther General Cancer Care Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Park Ridge : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Park Ridge : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Park Ridge : Oncology Specialists, SC

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC SC - 5

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Park Ridge : Oncology Specialists, SC SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Peoria : Illinois Cancer Care IL Cancer Specialists Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Peoria : Illinois Cancer Care Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Schaumburg : Cancer Treatment Centers of America Seattle Cancer Wellness Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Indiana

Goshen :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Goshen : Indiana University Health Goshen Center for Cancer SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Goshen : Indiana University Health Goshen Center for Cancer SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Indianapolis : James Whitcomb Riley Hospital For Children Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Indianapolis : Indiana University

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Indianapolis : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Indianapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Indianapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Indianapolis : Indiana University Indiana Univ. - Purdue Univ. Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Indianapolis :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Indianapolis : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Lafayette : Horizon Oncology Center Horizon Oncology Ctr. Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Iowa

Iowa City : University of Iowa Hospitals and Clinics

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Iowa City : University of Iowa Hospitals & Clinics

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating Temozolomide, Decitabine, Panobinostat for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

Patients are needed to participate in a clinical research study evaluating Vemurafenib, Decitabine for the treatment of Metastatic Melanoma, Melanoma, BRAF-mutated Metastatic Melanoma or V600EBRAF-mutated Metastatic Melanoma

Sioux City : Siouxland Hematology-Oncology Associates LLP SHO

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kansas

Wichita : Cancer Center of Kansas

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kentucky

Lexington : Baptist Health Clinical Research Center & Lexington Cardiac Research Foundation

A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAFV600E/K Mutant Melanoma

Louisville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Louisville :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Louisville : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Louisville : James Graham Brown Cancer Center

Patients are needed to participate in a clinical research study of A-dmDT390-bisFv(UCHT1) and Ionizing Radiation to evaluate Melanoma

Louisiana

Baton Rouge : Hematology/Oncology Clinic

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Metairie : Crescent City Research Consortium, LLC SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

New Orleans : Crescent City Research

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

New Orleans : Tulane University

Patients are needed to participate in a clinical research study evaluating 4-Demethyl-4-cholestryloxycarbonylpenclomedine for the treatment of Primary Brain Tumors or Secondary Brain Tumors

Maine

Bangor : Eastern Maine Medical Center Research Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Maryland

Baltimore : The Johns Hopkins University

A clinical study for patients with Melanoma

Baltimore : St. Agnes Hospital St. Agnes Hospital (2) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Baltimore : Weinberg Cancer Institute at Franklin Square Hospital Dept of Oncology

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Baltimore : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Baltimore : Harry and Jeannette Weinberg Cancer Institute at Franklin Square

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Bethesda :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Lutherville : Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Lutherville : Johns Hopkins Medicine

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Lutherville : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Lutherville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Massachusetts

Boston : Massachusetts General Hospital

A clinical study for patients with Melanoma

Boston : Dana-Farber Cancer Institute Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Boston : Dana-Farber Cancer Institute

A clinical research study of STA-9090 for the treatment of Ocular Melanoma

Boston : Massachusetts General Hospital

A clinical research study of STA-9090 for the treatment of Ocular Melanoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Boston : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using MGA271 for patients

Boston : Massachusetts General Hospital Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Boston : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Boston : Dana Farber Cancer Institute DFCI - Brookline

A Phase 1 clinical study for patients with Uveal Melanoma

Boston : Massachusetts General Hospital SC -6

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Boston :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Tremelimumab and MEDI3617 for the treatment of Metastatic Melanoma

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Beth Israel Deaconess Medical Center (BIDMC)

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Dana Farber Cancer Institute Dept. Onc

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Boston : Dana Farber Harvard Cancer Center

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Boston : Massachusetts General Hospital SC -6

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Boston : Massachusetts General Hospital Cancer Center

Patients are needed to participate in a clinical research study of MGA271 to evaluate Melanoma

Boston : Call for Information (Investigational Site 0009)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Boston : Call for Information (Investigational Site 0010)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Boston : Call for Information (Investigational Site 0004)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Boston :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Rockland : Please Contact U.S. Medical Information

A clinical trial seeking patients for a research study for the treatment of Melanoma

Michigan

Ann Arbor : University of Michigan, Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Ann Arbor : University of Michigan Int. Medicine Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Ann Arbor : University of Michigan Comprehensive Cancer Center SC-2

A Phase 4 clinical study for patients using Pasireotide

Ann Arbor : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Detroit : Karmanos Cancer Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Detroit : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Detroit : Teva Investigational Site 10670

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Detroit : Wayne State University/Karmanos Cancer Institute Wayne St

A Phase 1 clinical study for patients using LGK974

Detroit : Wayne State University/Karmanos Cancer Institute SC - 1

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Detroit :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grand Rapids : Mercy Health Saint Mary's Ofc of Research & Innovation

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Minnesota

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Minneapolis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Minneapolis : Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Minneapolis : Minnesota Oncology Hematology, P.A. Fridley Location

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Minneapolis : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Rochester : Mayo Clinic Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Rochester : Mayo Clinic - Rochester Onc Dept

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mississippi

Hattiesburg : Hattiesburgh Medical Oncology & Hematology

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hattiesburg : Forest General Hospital

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Jackson : Jackson Oncology Associates

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Missouri

Kansas City : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kansas City : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Manchester : Mercy Medical Research Institute SC-1

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

St. Louis : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

St. Louis : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Louis : Teva Investigational Site 10671

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

St. Louis : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

St. Louis : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

St. Louis :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

St. Louis : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

St. Louis : Saint Louis University Hospital Updated

Patients are needed to participate in a clinical research study evaluating Fosaprepitant for the treatment of Chemotherapy-induced Nausea and Vomiting

St. Louis : Washington University in St. Louis

Patients are needed to participate in a clinical research study evaluating NY-ESO-1 for the treatment of Melanoma

Montana

Billings : Billings Clinic Onc Dept Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nebraska

Lincoln : Southeast Nebraska Oncology Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Lincoln : Southeast Nebraska Oncology Cancer Center

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lincoln : Southeast Nebraska Hematology & Oncology Consultants

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Omaha : Nebraska Cancer Specialists, Midwest Cancer Center - Legacy

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Omaha : Nebraska Methodist Hospital Estabrook Cancer Center

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Omaha : Nebraska Methodist Hospital Nebraska Meth Hosp

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nevada

Las Vegas : Comprehensive Cancer Centers of Nevada CCC of Nevada- Southwest (2) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Las Vegas : Comprehensive Cancer Centers of Nevada CCC of Nevada (1)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Las Vegas : Comprehensive Cancer Centers of Nevada

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

New Hampshire

Lebanon : Dartmouth-Hitchcock Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Lebanon : Dartmouth Hitchcock Medical Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma

New Jersey

Basking Ridge : Memorial Sloan-Kettering Cancer Center at Basking Ridge

A clinical research study of LGX818 for the treatment of Melanoma

Brick : Meridian Health Systems

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Camden : Cooper Cancer Center SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Hackensack : Hackensack University Medical Center Dept of Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Morristown :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

New Brunswick : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

New Brunswick : Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School

Effects of Monoclonal Antibody GC1008 in Blood Samples From Patients With Unresectable Locally Advanced or Metastatic Kidney Cancer or Malignant Melanoma Treated on Clinical Trial NCI-06-C-0200

Randolph : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Verona : The Dermatology Group, P.C.

A clinical study for patients with Melanoma

New York

Bronx : Montefiore Medical Center SC-5

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using IDC-G305 for patients with Melanoma, Ovarian Cancer, Renal Cell Cancer or Non-small Cell Lung Cancer

Commack : Memorial Sloan-Kettering Cancer Center at Commack

A clinical research study of LGX818 for the treatment of Melanoma

New York : Memorial Sloan Kettering Cancer Center Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

New York : Memorial Sloan-Kettering Cancer Center

A clinical research study of LGX818 for the treatment of Melanoma

New York : Melanoma and Sarcoma Service / Memorial Sloan Kettering Cancer Center

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New York : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

New York : Memorial Sloan Kettering Cancer Ctr

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

New York : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

New York : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Dabrafenib for patients with Melanoma

New York : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

New York : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

New York : Memorial Sloan Kettering Cancer Center MSKCC 4

A Phase 1 clinical study for patients with Uveal Melanoma

New York : Memorial Sloan Kettering Cancer Center

A Phase 2 clinical study for patients with Uveal Melanoma

New York : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Melphalan and Dactinomycin for the treatment of Melanoma

New York : NYU Langone Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : NYU Clinical Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Center Dept of Onc..

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of RAD001 (Everolimus) and Pasireotide (SOM230) LAR to evaluate Uveal Melanoma

New York :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

New York : Icahn School of Medicine at Mount Sinai

Patients are needed to participate in a clinical research study of Vemurafenib to evaluate Melanoma

Rochester : University of Rochester MC / James P. Wilmot Cancer Center Rochester M.C. JP Wimot C Ctr.

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Rockville Centre : Memorial Sloan-Kettering Cancer Center at Mercy Medical Center

A clinical research study of LGX818 for the treatment of Melanoma

Sleepy Hollow : Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center

A clinical research study of LGX818 for the treatment of Melanoma

Troy : New York Oncology Hematology, P.C. NYOH Hematology Division

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

North Carolina

Chapel Hill : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Chapel Hill : Lineberger Comprehensive Cancer Center, University of North Carolina

A Phase 2 clinical study for patients with Stage III Melanoma, Stage IV Melanoma, Unresectable Melanoma or BRAF Mutant Melanoma

Chapel Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Durham :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Durham : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Durham : Duke University Health System

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Durham :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Durham : Duke Cancer Institute

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Winston-Salem : Wake Forest Baptist Health

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Winston-Salem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Winston-Salem : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

North Dakota

Fargo : Sanford Research/USD-Fargo

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ohio

Canton : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cincinnati : The Christ Hospital Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Melanoma, Unresectable (Stage III) Melanoma or Metastatic (Stage IV) Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Cincinnati : Oncology Hematology Care, Inc. Oncology Hematology Care (2) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Cincinnati : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Cleveland : University Hospitals Case Medical Center

A clinical study for patients with Melanoma

Cleveland : Taussig Cancer Institute / Cleveland Clinic Foundation

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Cleveland : Siedman Cancer Center / University Hospitals of Cleveland

A clinical research study of TRX518 for the treatment of Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies

Cleveland : Case Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Cleveland : Cleveland Clinic Cleveland Clinic (19) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Columbus : Ohio State University

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Whole-Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery (SRS) for the treatment of Recurrent Melanoma, Stage IV Melanoma or Tumors Metastatic to Brain

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Patients are needed to participate in a clinical research study of selinexor and Correlative studies to evaluate Recurrent Melanoma

Columbus : Mid Ohio Oncology/Hematology, Inc., dba, The Mark H. Zangmeister Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Patients with Metastatic Melanoma are needed to participate in a clinical research study evaluating ipilimumab, stereotactic radiosurgery and laboratory biomarker analysis

Middletown :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Oklahoma

Oklahoma City : University of Oklahoma Health Sciences Center Univ OK HSC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tulsa : Tulsa Cancer Institute SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oregon

Portland : Providence Cancer Center

A clinical research study of CAVATAK (Coxsackievirus A21, CVA21) for the treatment of Malignant Melanoma

Portland : Providence Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Portland : Providence Portland Medical Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Portland : Oregon Health & Science University OHSU Knight Cancer Institute Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Portland : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Portland : Providence Portland Medical Center

A Phase 1 clinical study for patients with Metastatic Melanoma

Portland : Northwest Cancer Specialists Compass Oncology - SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Kaiser Permanente Northwest Dept of Kaiser Northwest (3)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Oregon Health & Science University SC-7

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Portland : Providence Portland Medical Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Pennsylvania

Bethlehem : St Luke's University Hospital and Health Network

A clinical trial seeking patients for a research study for the treatment of Melanoma

Bethlehem : Clinical Site Updated

A clinical trial to evaluate treatments using HF10 plus Ipilimumab for patients with Malignant Melanoma

Bethlehem : St. Luke's Hospital and Health Network SC-3

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bethlehem : St. Luke's Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Easton : St. Luke's Hospital, Anderson Campus

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Hershey : Penn State University / Milton S. Hershey Medical Center SC-2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Philadelphia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Philadelphia : Teva Investigational Site 10669

A clinical trial to evaluate treatments using CEP-32496 for patients with Solid Tumors, Melanoma or Metastatic Colorectal Cancer

Philadelphia : Hospital of the University of Pennsylvania/Abramson Cancer Center

A clinical trial to evaluate treatments using MGA271 for patients

Philadelphia : Fox Chase Cancer Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Philadelphia : University of Pennsylvania Medical Center SC - 2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia : Thomas Jerfferson University Hospital SC

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Ipilimumab, Whole-Brain Radiation Therapy (WBRT) and Stereotactic Radiosurgery (SRS) for the treatment of Recurrent Melanoma, Stage IV Melanoma or Tumors Metastatic to Brain

Pittsburgh : Hillman Cancer Center

A clinical research study of Biospecimen banking for the treatment of Melanoma

Pittsburgh : UPMC Cancer Centers

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Pittsburgh : UPMC Hillman Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

Pittsburgh : University of Pittsburgh Cancer Institute Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Pittsburgh : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib 150 mg and Trametinib 2.0 mg for patients with Melanoma and Brain Metastases

Pittsburgh : Hillman Cancer Center

A clinical trial to evaluate treatments using High-dose Interferon alfa-2b and Vemurafenib for patients with Melanoma

Pittsburgh : Hillman Cancer Center

A Phase 1 clinical study for patients with Melanoma

Pittsburgh : University of Pittsburgh Medical Center SC-4

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pittsburgh : University of Pittsburgh Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Pittsburgh : University of Pittsburgh Cancer Institute SC-2

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pittsburgh : UPCI Cancer Center

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

South Carolina

Charleston : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Charleston : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Spartanburg : Gibbs Cancer Center & Research Institute Spartanburg Reg. Healthcare Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Tennessee

Chattanooga : Chattanooga Oncology and Hematology Assoicates, PC Chattanooga Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Knoxville : University of Tennessee

A clinical research study of Autologous Dendritic Cell-Tumor Cell Immunotherapy (DC-TC) and Autologous PBMCs in GM-CSF (MC) for the treatment of Stage IV Melanoma or Stage III Melanoma

Knoxville : University of Tennessee Medical Center

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Memphis : St. Jude Children'S Research Hospital Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Memphis : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Memphis : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Memphis : The West Clinic Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Memphis : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Memphis : University of Tennessee Cancer Institute Dept of Onc

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Memphis :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Nashville : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Nashville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nashville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nashville : Sarah Cannon Research Institute Onc Dept

A clinical trial seeking patients for a research study for the treatment of Melanoma

Nashville : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Nashville : Sarah Cannon Research Institute Tennessee Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using MGA271 for patients

Nashville : Sarah Cannon Research Institute

A Phase 1 clinical study for patients with Malignant Melanoma

Nashville : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Nashville : Sarah Cannon Research Institute SC - 2

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Texas

Austin : Austin Cancer Centers Austin Cancer Center (2) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Dallas : Updated

A clinical research study of Zelboraf (vemurafenib) for the treatment of Malignant Melanoma

Dallas : Texas Oncology Texas Oncology - Sammons Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Dallas : Texas Oncology SC Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Dallas : Mary Crowley Cancer Research Centers

A clinical trial to evaluate treatments using pbi-shRNA STMN1 LP for patients with Advanced Cancer, Metastatic Cancer or Solid Tumors

Dallas :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Dallas : Mary Crowley Medical Center

A Phase 2 clinical study for patients with Melanoma

Dallas : University of Texas Southwestern Medical Center SC (5)

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dallas : Baylor Health Care System/Sammons Cancer Center Oncology

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Dallas : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Dallas : University of Texas Southwestern Medical Center SC-5

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Dallas : Baylor Health Care System/Sammons Cancer Center Oncology

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Dallas :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Dabrafenib, Trametinib and Surgery for the treatment of Melanoma, Malignant Melanoma Stage IV or Metastatic Melanoma

Houston : The University Of Texas Md Anderson Cancer Center Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Houston : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Melanoma

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Houston : MD Anderson Cancer Center/University of Texas MD Anderson Cancer Center (3) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Houston : Oncology Consultants Oncology Group Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using investigational drug INGN 241 for patients with Malignant Melanoma or Neoplasm Metastasis

Houston : University of Texas/MD Anderson Cancer Center MD Anderson 2

A Phase 1 clinical study for patients using LGK974

Houston : MD Anderson Cancer Center

A Phase 1 clinical study for patients with Metastatic Melanoma or Other Advanced Solid Tumors

Houston : GSK Investigational Site

A Phase 1 clinical study for patients with Solid Tumours

Houston : University of Texas MD Anderson Cancer Center Updated

A Phase 2 clinical study for patients with Melanoma

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating DCVax-Direct

Houston :

Patients are needed to participate in a clinical research study evaluating MPDL3280A and Vemurafenib (Zelboraf®) for the treatment of Malignant Melanoma

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ipilimumab to evaluate Melanoma

Houston : University of Texas Health Science Center Univ.TX Memorial Herman Cancer

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Houston :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Melanoma

San Antonio : South Texas Accelerated Research Therapeutics

A clinical trial to evaluate treatments using AM0010 in Patients With Advanced Solid Tumors

San Antonio : The START Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Tyler : Tyler Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Utah

Murray : Intermountain Medical Center Intermountain Healthcare Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Murray : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Salt Lake City : Huntsman Cancer Institute

A clinical research study of CAVATAK (Coxsackievirus A21, CVA21) for the treatment of Malignant Melanoma

Salt Lake City : Primary Children'S Medical Center Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Salt Lake City : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Salt Lake City : Clinical Site Updated

A clinical trial to evaluate treatments using HF10 plus Ipilimumab for patients with Malignant Melanoma

Salt Lake City : Huntsman Cancer Institute

A Phase 2 clinical study for patients with Melanoma

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study evaluating Talimogene laherparepvec for the treatment of Melanoma

Vermont

Burlington :

A Phase 1/Phase 2 clinical study for patients with Unresectable Stage III or IV Melanoma

Colchester : Fletcher Allen Healthcare SC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Virginia

Charlottesville : University Of Virginia Health System

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Charlottesville : University of Virginia

Patients are needed to participate in a clinical research study of IDO1 inhibitor INCB024360, MELITAC 12.1 peptide vaccine and laboratory biomarker analysis

Fairfax : Virginia Cancer Specialists, PC Virginia Cancer Specialists Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Fairfax : Virginia Cancer Specialists, PC

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Washington

Everett : Providence Regional Cancer Partnership Providence Reg. Cancer (2) Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Everett : Providence Regional Cancer Partnership

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Seattle : University of Washington, Seattle Cancer Care Alliance

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma

Seattle : Seattle Cancer Care Alliance

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Seattle : Swedish Cancer Institute Swedish Cancer Institute (SC)

A Phase 4 clinical study for patients using Pasireotide

Seattle : Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : University of Washington Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study of ID-LV305 for Patients With Locally Advanced, Relapsed or Metastatic Cancer

Seattle : Call for Information (Investigational Site 0006)

Patients are needed to participate in a clinical research study of MK-3475, PegIFN-2b and Ipilimumab to evaluate Renal Cell Carcinoma or Melanoma

Seattle : Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Patients are needed to participate in a clinical research study of Plasmid INTERLEUKIN-12 and Intratumoral Electroporation to evaluate Melanoma

Spokane : Evergreen Hematology & Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Tacoma : Northwest Medical Specialties Hematology/Oncology Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Tacoma : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib 150 mg twice a day (BID), Rabeprazole 40 mg once daily (OD) and Rifampin 600 mg OD for patients with Cancer

Wenatchee : Wenatchee Valley Medical Center Wenatchee Valley Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Wenatchee : Wenatchee Valley Medical Center Wenatchee Valley

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Yakima : Yakima Valley Memorial Hospital North Star Lodge Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Wisconsin

Milwaukee : Research Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Milwaukee : Medical College of Wisconsin Cancer Ctr.-Froedtert Hospital Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Milwaukee : Aurora Research Institute Updated

A clinical trial seeking patients for a research study for the treatment of Tumor Pathway Activations Inhibited by Dovitinib

Argentina

Buenos Aires : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Buenos Aires : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Buenos Aires : Instituto Médico Alexander Fleming

A clinical trial to evaluate treatments using CSF470 vaccine, BCG, Molgramostim and interferon alpha 2b for patients with Cutaneous Melanoma

Caba : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Capital Federal : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ciudad Autonoma Buenos Aires : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Cordoba : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Derqui-Pilar : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pergamino : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Rio Negro : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Rosario : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Rosario : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Rosario : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rosario- Santa Fe : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Santa Fe : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tucuman : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Viedma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Australia

Adelaide : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Adelaide : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bedford Park : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Box Hill : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Box Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Camperdown : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Canberra : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Corrimal : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Douglas : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Frankston : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gateshead : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Gateshead : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Gateshead : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Greenslopes : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Greenslopes : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heidelberg : Austin Health, LICR Melbourne Austin Branch

A clinical research study of Bacillus Calmette-Guérin (BCG) vaccine and Ipilimumab for the treatment of Metastatic Melanoma

Heidelberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Herston :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Launceston : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melbourne : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melbourne : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nedlands : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nedlands : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

North Sydney : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

North Sydney : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

North Sydney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

North Sydney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Perth : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Prahran : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Southport : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Townsville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tweed Heads : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tweeds Head : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Waratah : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Westmead : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Westmead : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Westmead : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Westmead :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Wodonga : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wollongong : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Woodville : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Woodville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Woolloongabba : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Woolloongabba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Woolloongabba : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Austria

Graz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Graz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Graz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Innsbruck : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Innsbruck : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Linz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Linz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Linz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Salzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Salzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Salzburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Vienna : Medizinische Universität Wien, Abteilung für Dermatologie

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Vienna : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wels : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wien : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Wien : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Belgium

Antwerpen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brasschaat : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Brugge : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Brugge : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Brussels : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brussels : Cliniques universitaires Saint-Luc, Centre du Cancer

A Phase 1/Phase 2 clinical study for patients with Melanoma

Brussels : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brussels : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Brussels : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Brussels : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bruxelles : Cliniques Universitaires St-Luc, Service d'oncologie médicale

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Jules Bordet Institute

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Bruxelles : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Bruxelles : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Edegem :

A clinical research study for the treatment of Malignant Melanoma

Edegem : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Edegem : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Edegem : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Edegem : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gent : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Gent : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Gent : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Hasselt : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Hasselt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kortrijk : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kortrijk : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Kortrijk : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Kortrijk : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Leuven : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leuven : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Leuven : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Leuven : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leuven : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Leuven : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Liege : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Liege : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Liege : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Liège : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wilrijk : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Wilrijk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brazil

Belo Horizonte : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Curitiba : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Goiânia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ijui : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ijui :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Ijuí : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Passo Fundo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Passo Fundo :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Porto Alegre : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto Alegre : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto Alegre :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Rio de Janeiro :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Sao Paulo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

São Paulo - SP : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Canada

Calgary : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Edmonton : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Edmonton : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Edmonton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Edmonton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Greenfield Park :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Halifax : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Hamilton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Hamilton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hamilton : Juravinski Cancer Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

London : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

London : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Moncton : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montreal : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Montreal : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Montreal : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Montreal : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Montreal : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Montréall : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Oshawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ottawa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ottawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quebec : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quebec : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Québec : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Saint John : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sainte-Foy : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Saskatoon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toronto : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Toronto : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Toronto : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Toronto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Toronto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Toronto : The Hospital for Sick Children

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Vancouver : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Windsor : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Winnipeg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

China

Beijing : Beijing Shijitan Hospital,CMU

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Shanghai : Fudan University Shanghai Cancer Center

A clinical research study of Recombinant hGM-CSF Herpes Simplex Virus Injection for the treatment of Melanoma, Liver Cancer, Pancreatic Cancer or Lung Cancer

Colombia

Bogotá : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Croatia

Pula : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Varazdin : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Varazdin :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Zagreb : Updated

A clinical trial seeking patients for a Malignant Melanoma treatment research study

Zagreb : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Zagreb :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Cyprus

Nicosia :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Czech Republic

Brno : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brno : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Brno : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brno : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hradec Kralove : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Hradec Kralove : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Hradec Kralove : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Olomouc : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Olomouc : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Olomouc : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Olomouc : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ostrava :

A clinical research study for the treatment of Malignant Melanoma

Ostrava - Poruba : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Ostrava Poruba : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ostrava Poruba : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Prague : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Praha : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Praha : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Praha : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Praha : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Praha 10 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Praha 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Praha 10 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Praha 2 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Praha 2 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Praha 2 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Zlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Denmark

Århus C : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Copenhagen : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Herlev : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Odense : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Egypt

Alexandria :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Cairo :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Dakahlia :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Tanta :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Estonia

Tallinn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tallinn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tartu : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Finland

Hus : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Tampere : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

France

Angers : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Angers : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Bayonne : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Besancon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Besançon : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Besançon Cedex : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bordeaux : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bordeaux : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : CHU Hôpital Saint André

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Bordeaux : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bordeaux Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bordeaux Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Boulogne Billancourt : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Boulogne Billancourt : AP-HP Hôpital Ambroise Paré

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Boulogne Billancourt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Boulogne sur Mer : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Boulogne-Billancourt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Boulogne-Billancourt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brest : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Brest cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Brest Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bron Cedex : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Caen : CHRU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Clermont Ferrand Cédex 1 : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dijon : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Dijon : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grenoble : CHU Michallon

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Grenoble : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Grenoble Cédex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Grenoble Cédex 9 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Le Kremlin Bicetre : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Le Mans : CH

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Le Mans Cedex 09 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Le Mans Cedex 09 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lille : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lille : CHRU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Lille : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Lille : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

LILLE Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

LILLE Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lille Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Limoges : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Lyon : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Lyon : Institute for Pediatric Hemato-Oncology, Leon Berard Cancer Center

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Lyon Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lyon Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lyon sud : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Marseille : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Marseille : AP-HM

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Marseille : Hôpital Sainte Marguerite

Patients are needed to participate in a clinical research study evaluating masitinib and Dacarbazine for the treatment of Metastatic Melanoma

Marseille :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Marseille Cedex 05 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Marseille Cedex 5 : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Marseille Cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Marseille cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Montauban : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montivilliers : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Montpellier : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Montpellier cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nancy : Hôpital d'Enfants, CHU Nancy

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Nantes : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nantes : Centre Hospitalier Universitaire de Nantes

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Nantes Cedex 1 : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Nice : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nice : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Nice : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nice Cedex 2 : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Nice Cedex 3 : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nice Cedex 3 : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nouvelle caledonie : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Orléans : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Paris : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Paris : AP-HP Hôpital Saint Louis

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Paris : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Paris : Novartis Investigative Site

A Phase 1 clinical study for patients with Uveal Melanoma

Paris : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Paris : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Paris : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Paris : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Paris : Institut Curie

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Paris Cedex 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Paris Cedex 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Paris Cedex 10 : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Paris Cedex 5 : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Pierre Benite : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pierre Benite :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Pierre Bénite : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Pierre-Benite Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pierre-Benite Cedex : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Pierre-Benite Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pierre-Bénite cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pierre-Bénite cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Poitiers : CHU Milétrie

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Quimper : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Reims : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Reims : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Reims Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rennes : CHU Pontchaillou

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Rennes Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Rennes Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rouen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Saint-Etienne : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Soissons cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Strasbourg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Strasbourg Cedex : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toulouse : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Toulouse : CHU Hôpital Larrey

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Toulouse cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Toulouse Cedex 9 : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Toulouse cedex 9 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tours : CHU

A clinical trial to evaluate treatments using Imiquimod cream + surgery and vehicle + surgery for patients with Lentigo Maligna Melanoma (Head or Neck)

Tours Cedex 9 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Vandoeuvre Les Nancy : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Villejuif : Institut Gustave Roussy

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Villejuif Cedex : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Villejuif cedex : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Villejuif cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Villejuif cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Villejuif Cedex : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Germany

Aachen : Dept of Dermatology, University of Aachen

A Phase 3 clinical study for patients with Melanoma

Augsburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bayreuth : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Berlin : HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie

A clinical trial to evaluate treatments for patients with Colo-rectal Cancer, Stomach Cancer or Melanoma

Berlin : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Berlin : Dept of Dermatology, University of Berlin Charite

A Phase 3 clinical study for patients with Melanoma

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Berlin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Berlin : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bochum : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bochum : Dept of Dermatology, University of Bochum

A Phase 3 clinical study for patients with Melanoma

Bochum : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bochum : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bonn : Neurologische Universitaetsklinik Bonn

A clinical trial seeking patients for a research study for the treatment of Leptomeningeal Metastasis From Malignant Melanoma

Bonn : Medizinisches Zentrum Bonn Friedensplatz

A Phase 3 clinical study for patients with Melanoma

Buxtehude : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Buxtehude : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Chemnitz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Darmstadt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Dessau-Roblau : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dortmund : Klinikum Dortmund Ggmbh Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Dresden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dresden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Dresden : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Düsseldorf : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erfurt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Erfurt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Erlangen : Uniklinik Erlangen Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Essen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Essen : Novartis Investigative Site

A Phase 1 clinical study for patients with Metastatic Melanoma and Merkel Cell Carcinoma

Essen : Dept of Dermatology, University of Essen

A Phase 3 clinical study for patients with Melanoma

Essen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Essen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Essen : Medizinische Fakultät der Universität Duisburg-Essen

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Essen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Essen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Essen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Frankfurt : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Frankfurt : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Frankfurt : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Frankfurt / Main : Dept of Dermatology, University of Frankfurt

A Phase 3 clinical study for patients with Melanoma

Frankfurt/Oder : Dermatology, Klinikum Frankfurt/Oder

A Phase 3 clinical study for patients with Melanoma

Freiburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Freiburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Freiburg : University Medical Center Freiburg, Department of Dermatology

Patients are needed to participate in a clinical research study evaluating psycho-oncological intervention for the treatment of Malignant Melanoma

Freiburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Freiburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gera : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Gera : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Gera : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Gera : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Göttingen :

A clinical research study for the treatment of Malignant Melanoma

Hamburg : Uniklinik Hh Eppendorf Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Hamburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hamburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Hamburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Hannover : Dept of Dermatology, University of Hannover

A Phase 3 clinical study for patients with Melanoma

Hannover : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Hannover : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hannover : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hannover : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heidelberg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Heidelberg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Heidelberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Heidelberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Heidelberg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Heidelberg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Heilbronn : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Homburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Homburg/Saar : Dept of Dermatology, Saarland University

A Phase 3 clinical study for patients with Melanoma

Jena : Dept of Dermatology, University of Jena

A Phase 3 clinical study for patients with Melanoma

Jena : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kassel : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kiel : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Kiel : Dept of Dermatology, University of Schleswig-Holstein Campus Kiel

A Phase 3 clinical study for patients with Melanoma

Kiel : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Kiel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Kiel : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kiel :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Kiel : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Koblenz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Koeln : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Köln : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Köln : University Medical Center Collogne, Department of Dermatology

Patients are needed to participate in a clinical research study evaluating psycho-oncological intervention for the treatment of Malignant Melanoma

Leer :

A clinical research study for the treatment of Malignant Melanoma

Leipzig : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lübeck : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lübeck : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lübeck : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lüdenscheid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Ludwigshafen : Dermatology, Klinikum Ludwishafen

A Phase 3 clinical study for patients with Melanoma

Ludwigshafen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Luebeck : Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck

A Phase 3 clinical study for patients with Melanoma

Luebeck : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Magdeburg : Dept of Dermatology, Univeristy of Magdeburg

A Phase 3 clinical study for patients with Melanoma

Magdeburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Magdeburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mainz : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Mainz : Hautklinik und Poliklinik Universitätsmedizin der Johannes-Gutenberg Universität Mainz

A clinical trial to evaluate treatments using IVAC MUTANOME, RBL001/RBL002 for patients with Melanoma

Mainz : Dept of Dermatology, University of Mainz

A Phase 3 clinical study for patients with Melanoma

Mainz : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mainz : Universtitätsmedizin der Johannes-Gutenberg Universtität

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Mainz : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Mainz :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Mainz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Manheim : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Mannheim : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Mannheim : Dept of Dermatology, University of Mannheim

A Phase 3 clinical study for patients with Melanoma

Mannheim : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Mannheim : Universitätsklinik Mannheim

Patients are needed to participate in a clinical research study evaluating RBL001/RBL002 for the treatment of Melanoma

Marburg : Dept of Dermatology, University of Marburg

A Phase 3 clinical study for patients with Melanoma

Marburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Minden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Minden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Muenchen : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Muenchen : Dept of Dermatology, University of Muenchen

A Phase 3 clinical study for patients with Melanoma

Muenchen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Muenchen : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Muenchen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Muenchen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Muenster : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Muenster : Dept of Medical Oncology, Fachklinik Hornheide

A Phase 3 clinical study for patients with Melanoma

Muenster : Dept of Dermatology, University of Muenster

A Phase 3 clinical study for patients with Melanoma

Muenster : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Muenster : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Muenster : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

München : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Munster : Uniklinik Muenster Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Münster : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Nuernberg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nuernberg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nuernberg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Plauen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Quedlinburg :

A clinical research study for the treatment of Malignant Melanoma

Quedlinburg : Dermatology, Klinikum Dorothea Christiane Erxleben

A Phase 3 clinical study for patients with Melanoma

Quedlinburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Quedlinburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Quedlinburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Recklinghausen :

A clinical research study for the treatment of Malignant Melanoma

Recklinghausen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Regensburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Regensburg : University of Regensburg

Patients are needed to participate in a clinical research study evaluating dacarbazine (DTIC), Trofosfamide, Etoricoxib, Pioglitazone, Temsirolimus for the treatment of Advanced Melanoma

Rostock :

A clinical research study for the treatment of Malignant Melanoma

Schwäbisch Hall : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Schwerin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Schwerin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Stade : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Stade : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tübingen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Tübingen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tübingen : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tuebingen : University Hospital

A clinical research study of Arm 1: L19IL2 + Dacarbazine and Arm 2: Dacarbazine for the treatment of Metastatic Melanoma Stage IV

Tuebingen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tuebingen : Dept of Dermatology, University of Tuebingen

A Phase 3 clinical study for patients with Melanoma

Tuebingen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tuebingen :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Ulm : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Ulm : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ulm : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Wiesbaden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wuerzburg : Dept of Dermatology, University of Wuerzburg

A Phase 3 clinical study for patients with Melanoma

Wuerzburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Wurzburg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Würzburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Würzburg : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Würzburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Würzburg : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Greece

Athens : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Thessaloniki : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Thessaloniki : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hong Kong

Tuen Mun : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Cancer

Hungary

Budapest : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Budapest : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Budapest : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Budapest : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Debrecen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Szolnok : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ireland

Cork : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Dublin : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Dublin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dublin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Dublin : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Galway :

A clinical research study for the treatment of Malignant Melanoma

Galway : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Galway : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tullamore : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Israel

Beer Sheva : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Beer Sheva : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Haifa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Haifa : Rambam Health Care Campus

A clinical trial seeking patients for a research study for the treatment of Skin Lesions

Haifa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Haifa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Haifa : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Jerusalem : Oncology institute, Shaare Zedek Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Jerusalem : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Jerusalem : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Jerusalem : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Jerusalem : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Jerusalem : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Jerusalem : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kiryat Bialik : Clalit Health Services

A clinical trial seeking patients for a research study for the treatment of Skin Lesions

Petach Tikva : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Petach-Tikva :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Ramat Gan : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ramat Gan : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Ramat Gan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ramat Gan : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Tel Aviv : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tel Aviv : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Tel Hashomer : Oncology Institute, Sheba Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Tel Hashomer : Ella Institute, Oncology institute, Sheba Medical Center

A clinical research study of IVIG and Biological Therapy for the treatment of Cancer of Colon, Malignant Melanoma or Urologic Cancer

Tel Hashomer : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Tel Hashomer : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Italy

Ancona : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Ancona : A.O. UNIVERSITARIA OSPEDALI RIUNITI - OSPEDALE UMBERTO I DI ANCONA - ANCONA (AN) (Italy)

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Ancona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bari : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bari : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bari : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bergamo : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bergamo : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bergamo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Bergamo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bologna : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Brescia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Brescia : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Candiolo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Candiolo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Catania : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Genova : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Genova : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Genova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Genova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Genova : Children's Hospital Largo

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Genova :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Lecco : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Meldola : Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Meldola (Fc)

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Milan : Fondazione IRCCS Istituto Nazionale dei Tumori

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Milan : European Institute of Oncology

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Milan : Istituto Nazionale Tumori

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Milano : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Milano : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Milano : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Milano : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Milano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Milano :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Modena : A.O. UNIVERSITARIA POLICLINICO DI MODENA (Italy)

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Monza : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Napoli : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Napoli : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Napoli : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Napoli : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Padova : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Padova : Vanna Chiarion-Sileni, MD

A clinical trial to evaluate treatments using Anti-B-RAF for patients with Metastatic Melanoma

Padova : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Padova : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Padova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Padova : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Padova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Padova : Clinica di Oncoematologia

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Palermo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pavia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pisa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pisa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ragusa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Roma : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Roma : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Roma : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Roma :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Rozzano : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Rozzano : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of Arm 1: L19IL2 + Dacarbazine and Arm 2: Dacarbazine for the treatment of Metastatic Melanoma Stage IV

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Siena : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Siena : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Siena : Azienda Ospedaliera Universitaria Senese

Patients are needed to participate in a clinical research study of F16IL2 in combination with paclitaxel to evaluate Tumour or Breast Cancer

Siena : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Terni : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Torino : l'Azienda Ospedaliera Regina Margherita - Sant Anna

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Udine : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Japan

Chiyoda-Ku, Tokyo : MSD K.K.

A clinical research study of pembrolizumab for the treatment of Melanoma

Chuo-ku : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Chuo-ku : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Fukuoka-city : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hirakata-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Matsumoto : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Matsumoto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Osaka : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Shizuoka : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tokyo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Tsu : Mie University Hospital

A clinical trial to evaluate treatments using TBI-1201, Cyclophosphamide and Fludarabine for patients with Solid Tumors

Korea, Republic of

Seoul : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Cancer

Seoul : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Cancer

Seoul : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Seoul :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Seoul :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Seoul :

Patients are needed to participate in a clinical research study of vemurafenib and tizanidine to evaluate Malignant Melanoma, Neoplasms

Mexico

Cuernavaca : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Df : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Guadalajara : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Leon, Guanajato : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Mexico : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

México : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Monterrey : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Morelia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Netherlands

Amsterdam : Novartis Investigative Site

A clinical research study for the treatment of Melanoma

Amsterdam : Local Institution

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Amsterdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Amsterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Amsterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Amsterdam : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Breda : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Enschede : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Groningen : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Groningen : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

Groningen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Groningen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Heerlen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Leeuwarden : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leiden : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Leiden : Novartis Investigative Site

A Phase 1 clinical study for patients with Uveal Melanoma

Leiden : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leiden : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Leiden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Leiden : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Maastricht : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Maastricht : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Nijmegen : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Nijmegen : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nijmegen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Nijmegen : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Rotterdam : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Rotterdam : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Rotterdam : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Utrecht : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LEE011 and MEK162 to evaluate Locally Advanced or Metastatic NRAS Mutant Melanoma

Zwolle : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Zwolle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

New Zealand

Auckland : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Christchurch : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wellington : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Norway

Ålesund : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Oslo : Oslo University Hospital Radiumhospitalet

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

Oslo : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Oslo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Stavanger : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Poland

Bydgoszcz : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Gdansk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Konin : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Łódź : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Olsztyn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Poznan : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Poznan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Poznan : WCO (Great Poland Cancer Centre)

Patients are needed to participate in a clinical research study of AGI-101H Vaccine to evaluate Melanoma

Warszawa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Warszawa : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Warszawa : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Warszawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Warszawa : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Warszawa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Warszawa : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wroclaw : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wroclaw :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Wrocław : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Portugal

Almada : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Coimbra : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Evora : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lisboa : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Porto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Russian Federation

Chelyabinsk : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Krasnodar : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Moscow : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Moscow : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Moscow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Moscow : Merck Sharp & Dohme IDEA, Inc.

Patients are needed to participate in a clinical research study evaluating Pegylated Interferon Alfa-2b for the treatment of Melanoma

Moscow : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ryazan : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ryazan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Ryazan : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Saint-Petersburg : Novartis Investigative Site

A Phase 4 clinical study for patients using Pasireotide

St. Petersburg : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St. Petersburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Volzhsky : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Serbia

Belgrade : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Belgrade : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Belgrade : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Sremska Kamenica : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Singapore

Singapore : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Slovakia

Bratislava : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bratislava : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Bratislava :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Poprad : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

South Africa

Bloemfontein : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bloemfontein : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Cape Town :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

George : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Groenkloof : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Groenkloof : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Johannesburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Johannesburg : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Observatory : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Port Elizabeth :

Patients are needed to participate in a clinical research study of vemurafenib and rifampin to evaluate Malignant Melanoma, Neoplasms

Pretoria : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Pretoria : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pretoria : Updated

Patients are needed to participate in a clinical research study evaluating Zelboraf for the treatment of Malignant Melanoma

Pretoria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pretoria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Sandton : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Spain

Alicante : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Badajoz : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Badalona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Badalona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Barcelona : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Barcelona : H. Clinic de Barcelona

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Barcelona : Novartis Investigative Site

A Phase 1 clinical study for patients using LGK974

Barcelona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Barcelona : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Barcelona : Hospital Universitario Vall D`Hebron

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Barcelona : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Barcelona : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cartagena (Murcia) : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

El Palmar : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Esplugues De Llobregas :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Esplugues de Llobregat- Barcelona : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Granada : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Hospitalet de LLobregat : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Jerez de La Frontera : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

La Coruna : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Las Palmas de Gran Canaria : H. Insular de Canarias

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Las Palmas De Gran Canaria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Las Palmas De Gran Canaria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Las Palmas de Gran Canaria : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Las Palmas de Gran Canarias : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

L'Hospitalet de Llobregat : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lleida : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Madrid : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Madrid : H. U. Gregorio Marañón

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Madrid : Spanish National Cancer Research Centre

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Madrid : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Madrid : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Majadanonda : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Malaga : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Málaga : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Marbella : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Oviedo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Palma de Mallorca : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pamplona : Local Institution

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Pamplona : Clínica Universidad de Navarra

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Pamplona : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Pamplona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pamplona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Pamplona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pamplona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Pamplona : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

San Sebastián : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

San Sebastián : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Santander : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Santiago Compostela : Local Institution Updated

Patients are needed to participate in a clinical research study of Nivolumab (BMS-936558) to evaluate Melanoma

Santiago de Compostela : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Santiago de Compostela : H. Clínico de Santiago

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Sevilla : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Sevilla : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Sevilla : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Sevilla : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Sevilla : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Sevilla :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Sevilla : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Toledo : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Valencia : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Valencia : H. General de Valencia

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Valencia : Instituto Valenciano de Oncología

A clinical trial seeking patients for a research study for the treatment of Melanoma or Brain Metastases

Valencia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Valencia : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Valencia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Valencia : Unidad de Oncologia Pediatrica, Hospital Universitario la Fe

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Sweden

Gavle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Goteborg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Göteborg : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Jönköping : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Linköping : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Lund : Lunds Universitetssjukhus

A Phase 2 clinical study for patients with Malignant Melanoma

Lund : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lund : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Lund : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Stockholm : Södersjukhuset

A Phase 2 clinical study for patients with Malignant Melanoma

Stockholm : Karolinska Sjukhuset

A Phase 2 clinical study for patients with Malignant Melanoma

Stockholm : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Stockholm : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Umea : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Umeå : Norrlands Universitetssjukhus

A Phase 2 clinical study for patients with Malignant Melanoma

Uppsala : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Växjö : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Switzerland

Baden : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Basel : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Basel : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bern : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Chur : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Genève : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lausanne : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lausanne : Novartis Investigative Site

A Phase 1 clinical study for patients with Metastatic Melanoma and Merkel Cell Carcinoma

Lausanne : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Lugano : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Zuerich : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Melanoma

Zuerich : Novartis Investigative Site

A Phase 1 clinical study for patients with Metastatic Melanoma and Merkel Cell Carcinoma

Zurich : Universitäts-Kinderklinik

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Zürich : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Zürich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Zürich : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Zürich : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Taiwan

Taichung : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Taipei : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Cancer

Taipei : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

Taipei : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Taoyuan : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Thailand

Songkla : GSK Investigational Site

A clinical trial to evaluate treatments using Dabrafenib and Trametinib for patients with Cancer

Turkey

Adana :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Adana :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Afyon :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ankara : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Antalya : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Ba?kesir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Bursa :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Denizli :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Diyarbakir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Edirne :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Erzurum :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Gaziantep :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Isparta :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Istanbul :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Izmir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Izmir : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Kayseri :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Konya :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Malatya :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

S?hhiye, ANKARA :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Tokat :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Trabzon :

Patients are needed to participate in a clinical research study for the treatment of Breast Cancer, Malignant Melanoma, Gastric Cancer, Colorectal Cancer

Ukraine

Dnipropetrovsk : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Lviv : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

United Kingdom

Birmingham : Queen Elizabeth Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Birmingham : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Birmingham : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Birmingham : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Bristol : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Bristol : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Bristol : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Bristol : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Broomfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Cambridge : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cambridge : Cambridge University Hospitals NHS Foundation Trust

A clinical trial to evaluate treatments using Pazopanib for patients

Cambridge : Addenbrooke's Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Cambridge : Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital)

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Cambridge : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Cambridge : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Cardiff : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Cardiff : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Chelmsford : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Dundee : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Edinburgh : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Exeter : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Glasgow : The Beatson Institute

A Phase 1 clinical study for patients with Malignant Melanoma

Glasgow : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Glasgow : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Guildford : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Hull : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Kings Lynn : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Leeds : St James University Hospital

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

Leeds : St James' Institute of Oncology

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Leeds : St James Hospital

A Phase 1 clinical study for patients with Malignant Melanoma

Leeds : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Leeds : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Leeds : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Leeds : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Lincoln : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Institute of Cancer Research

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

London : Guy's Hospital

A clinical trial to evaluate treatments using LTX-315 for patients with Transdermally Accessible Tumours

London : The Royal Marsden Hospital

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

London : Please contact the Merck KGaA Communication Center Updated

A Phase 1 clinical study for patients with Solid Tumors

London : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

London : King's College London Guy's Hospital Campus

Patients are needed to participate in a clinical research study evaluating E7449 alone, E7449 plus TMZ and E7449 plus carboplatin and paclitaxel

London : Novartis Investigative Site

Patients are needed to participate in a clinical research study of AEB071 and MEK162 to evaluate Uveal Melanoma

London : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

London : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

London : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Manchester : Christie Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Manchester : The Christie NHS Foundation Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Manchester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Merseyside : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Merseyside : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Newcastle : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Newcastle upon Tyne : Newcastle upon Tyne Hospitals

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Newcastle upon Tyne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Newcastle upon Tyne :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Newcastle Upon Tyne and Wear : Newcastle Upon Tyne NHS Foundation Trust

Patients are needed to participate in a clinical research study evaluating E7449 alone, E7449 plus TMZ and E7449 plus carboplatin and paclitaxel

Northwood : Research Site

A clinical trial to evaluate treatments using MEDI4736, Dabrafenib and Trametinib for patients with Melanoma

Northwood : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Northwood : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Northwood : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Norwich : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Nottingham : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Nottingham : Department of Clinical Oncology, City Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Nottingham : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Oxford : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Oxford : NIHR Biomedical Research Centre

A Phase 1 clinical study for patients with Malignant Melanoma

Oxford : Oxford University Hospitals NHS Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Oxford : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Oxfordshire : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Plymouth : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Poole : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Preston : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Preston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Preston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Preston : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Sheffield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Southampton : Department of Medical Oncology, Southampton General Hospital

A clinical trial to evaluate treatments using SCIB1 for patients with Malignant Melanoma

Southampton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

St Helen's : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Staffordshire : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Surrey : University of Surrey

A clinical research study of CVA21 for the treatment of Non-small Cell Lung Cancer, Castrate-resistant Prostate Cancer, Melanoma or Bladder Cancer

Surrey : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Surrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of LGX818, LGX818+MEK162 and vemurafenib to evaluate Melanoma

Sutton : Local Institution Updated

A clinical research study of Ipilimumab for the treatment of Malignant Melanoma

Sutton : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib, Trametinib and Placebos for the treatment of Melanoma

Sutton : Royal Marsden Hospital

Patients are needed to participate in a clinical research study of nab-paclitaxel for Recurrent/ Refractory Solid Tumors

Sutton :

Patients are needed to participate in a clinical research study of vemurafenib to evaluate Malignant Melanoma

Swansea : Research Site

Patients are needed to participate in a clinical research study evaluating 75mg selumetinib, placebo and Dacarbazine for the treatment of Metastatic or Uveal Melanoma

Taunton, Somerset : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Truro : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Truro : Novartis Investigative Site

A Phase 3 clinical study for patients with Metastatic or Unresectable Cutaneous Melanoma

Truro, Cornwall : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Westcliff on Sea : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wirral : Clatterbridge Centre for Oncology NHS Foundation Trust

A clinical trial to evaluate treatments using Dacarbazine and Sunitinib for patients with Metastatic Uveal Melanoma

Wirral : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Wolverhampton : Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Wolverhampton : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma

Yeovil, Somerset : Local Institution

Patients are needed to participate in a clinical research study to evaluate Cutaneous Melanoma